{"id":1275,"date":"2025-11-21T06:37:08","date_gmt":"2025-11-21T06:37:08","guid":{"rendered":"https:\/\/snips.nutrifytoday.com\/blog\/?p=1275"},"modified":"2025-11-21T06:37:08","modified_gmt":"2025-11-21T06:37:08","slug":"anthocyanin-rich-bilberry-extract-shows-potential-benefits-in-ulcerative-colitis-results-from-a-randomized-controlled-trial","status":"publish","type":"post","link":"https:\/\/snips.nutrifytoday.com\/blog\/anthocyanin-rich-bilberry-extract-shows-potential-benefits-in-ulcerative-colitis-results-from-a-randomized-controlled-trial\/","title":{"rendered":"Anthocyanin-Rich Bilberry Extract Shows Potential Benefits in Ulcerative Colitis: Results from a Randomized Controlled Trial"},"content":{"rendered":"\n<p>This multicenter, double-blind, placebo-controlled trial evaluated the efficacy of anthocyanin-rich extract (ACRE), derived from bilberries, in patients with moderate-to-severe ulcerative colitis (UC). Although the study was prematurely terminated due to COVID-19, 34 patients were randomized, and 26 completed the protocol. Clinical response was observed in 50% of ACRE-treated patients versus 37.5% in the placebo group. While superiority was not statistically significant, ACRE led to meaningful reductions in fecal calprotectin (p = 0.035), indicating anti-inflammatory activity. Mayo scores improved in 77.8% of ACRE patients compared to 62.5% with placebo. ACRE was generally well tolerated, highlighting its potential as a supportive therapy for UC.<\/p>\n\n\n\n<p>Source: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39683589\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/39683589\/<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>This multicenter, double-blind, placebo-controlled trial evaluated the efficacy of anthocyanin-rich extract (ACRE), derived from bilberries, in patients with moderate-to-severe ulcerative colitis (UC). Although the study was prematurely terminated due to COVID-19, 34 patients were randomized, and 26 completed the protocol. Clinical response was observed in 50% of ACRE-treated patients versus 37.5% in the placebo group. [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1275","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/snips.nutrifytoday.com\/blog\/wp-json\/wp\/v2\/posts\/1275","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/snips.nutrifytoday.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/snips.nutrifytoday.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/snips.nutrifytoday.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/snips.nutrifytoday.com\/blog\/wp-json\/wp\/v2\/comments?post=1275"}],"version-history":[{"count":1,"href":"https:\/\/snips.nutrifytoday.com\/blog\/wp-json\/wp\/v2\/posts\/1275\/revisions"}],"predecessor-version":[{"id":1276,"href":"https:\/\/snips.nutrifytoday.com\/blog\/wp-json\/wp\/v2\/posts\/1275\/revisions\/1276"}],"wp:attachment":[{"href":"https:\/\/snips.nutrifytoday.com\/blog\/wp-json\/wp\/v2\/media?parent=1275"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/snips.nutrifytoday.com\/blog\/wp-json\/wp\/v2\/categories?post=1275"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/snips.nutrifytoday.com\/blog\/wp-json\/wp\/v2\/tags?post=1275"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}